Estrella Immunopharma
ESLA · NASDAQ
$0.40+$0.0201 (+5.29%)TodayMarket closed ·
Prev close $0.3799
Who owns ESLA
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 72.0% of ESLA’s shares.
- Eureka Therapeutics Inc58.7%
- Armistice Capital LLC9.2%
- Vanguard Capital Management, LLC1.0%
- Liu (Cheng Ph.D.)0.9%
- Next 6 largest institutions2.1%
- All other shareholders28.0%
| Holder | Shares | % of shares |
|---|---|---|
| Eureka Therapeutics Inc | 25.28M | 58.74% |
| Armistice Capital LLC | 3.98M | 9.24% |
| Vanguard Capital Management, LLC | 416.85K | 0.97% |
| Liu (Cheng Ph.D.) | 397.44K | 0.92% |
| Xu (Jiandong Peter) | 365.49K | 0.85% |
| Zhang (Hong) | 240.48K | 0.56% |
| Geode Capital Management, L.L.C. | 141.32K | 0.33% |
| Vanguard Fiduciary Trust Co | 64.92K | 0.15% |
| BlackRock Institutional Trust Company, N.A. | 49.66K | 0.12% |
| State Street Investment Management (US) | 43.25K | 0.10% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 268.61K | 0.62% |
| Vanguard Extended Market Index Fund | 148.25K | 0.34% |
| Fidelity Extended Market Index Fund | 80.88K | 0.19% |
| iShares Micro-Cap ETF | 50.31K | 0.12% |
| Fidelity Series Total Market Index Fund | 26.16K | 0.06% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of ESLA in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Liu Cheng | Option exercise | 100.00K | — |
| Liu Cheng | Option exercise | 100.00K | $81.50K |
| Xu Jiandong | Option exercise | 100.00K | — |
| Xu Jiandong | Option exercise | 100.00K | $81.50K |
Short interest
Settled Sep 30, 2026
- Shares short
- 214.03K
- Days to cover
- 4.66
- % of shares outstanding
- 0.50%
- Average daily volume
- 45.96K
- Change since last report
- +39.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.